发明名称 |
Methods of administering n-(5-tert-butyl-isoxazol-3-yl)-n?-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea to treat proliferative disease |
摘要 |
<p>Provided herein are methods of administering N -(5- tert -butyl-isoxazol-3-yl)- N '-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or a pharmaceutically acceptable salt or solvate thereof, to human patients. Specifically, dosing, dosing schedules or dosing regimens are provided herein. Further, pharmaceutical formulations are provided. Methods of treating proliferative diseases or FLT-3 mediated diseases in humans are also provided.</p> |
申请公布号 |
EP2596795(A1) |
申请公布日期 |
2013.05.29 |
申请号 |
EP20120197285 |
申请日期 |
2008.11.07 |
申请人 |
AMBIT BIOSCIENCES CORPORATION |
发明人 |
JAMES, JOYCE K.;EICHELBERGER, SHAWN R.;SAVALL, TRACI L. |
分类号 |
A61K31/5377;A61P35/00;A61P35/02 |
主分类号 |
A61K31/5377 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|